Nitroglycerin Transdermal Infusion System Patch
Product Images NDC 43598-893

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Nitroglycerin Transdermal Infusion System (NDC 43598-893). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nitroglycerin Chemical Structure (Nitroglycerin Patch 01)

Chemical structure diagram of Nitroglycerin, showing the molecular arrangement with nitro (CONO2) and hydroxyl groups connected to a glycerin backbone.*

FDA Label Image

Cross Section Of System (Nitroglycerin Patch 02)

A cross-sectional diagram of a Nitroglycerin Transdermal Infusion System patch showing two labeled layers: an impermeable backing on top and a nitroglycerin/adhesive layer beneath it. This illustrates the patch design that delivers nitroglycerin through the skin.*

FDA Label Image

Placement Area Image (Nitroglycerin Patch 03)

An anatomical illustration showing the application area for the Nitroglycerin Transdermal Infusion System patch. The diagram highlights the upper chest and shoulder region, indicating typical placement sites for the transdermal patch to deliver nitroglycerin through the skin.*

FDA Label Image

Application Figure Image (Nitroglycerin Patch 04)

An instructional diagram showing hands applying the Nitroglycerin Transdermal Infusion System patch. The illustration depicts the correct way to handle and apply the transdermal patch to the skin, emphasizing proper placement and technique.*

FDA Label Image

Application Figure Image (Nitroglycerin Patch 05)

An instructional illustration showing two hands holding and peeling apart a Nitroglycerin Transdermal Infusion System patch to separate the protective liners before application. The image demonstrates the correct method to prepare the patch for transdermal use.*

FDA Label Image

Application Figure Image (Nitroglycerin Patch 06)

An instructional illustration depicting the application of a Nitroglycerin Transdermal Infusion System patch on an upper chest area. The image shows a person placing the transdermal patch on the skin, demonstrating proper patch placement for delivering nitroglycerin through the skin.*

FDA Label Image

Application Figure Image (Nitroglycerin Patch 07)

An instructional illustration showing a hand holding a circular transdermal patch, with the other hand peeling away the backing from the patch to expose the adhesive side.*

FDA Label Image

Application Figure Image (Nitroglycerin Patch 08)

Illustration showing a step-by-step procedure for applying a Nitroglycerin Transdermal Infusion System patch. The image depicts a hand peeling the protective backing from the round patch, demonstrating the removal process before application to the skin.*

FDA Label Image

Application Figure Image (Nitroglycerin Patch 09)

Illustration showing the correct application of the Nitroglycerin Transdermal Infusion System patch on the upper arm of a person. The image demonstrates securing the patch in place on the skin, representing the transdermal route of administration for this prescription drug by Dr. Reddy's Laboratories, Inc.*

FDA Label Image

Application Figure Image (Nitroglycerin Patch 10)

Packaging label of Nitroglycerin Transdermal Infusion System patch showing the patch partially peeled from its backing. The image displays the transdermal patch dosage form used for topical application, manufactured by Dr. Reddy's Laboratories, Inc.*

FDA Label Image

Removal Figure Image (Nitroglycerin Patch 11)

An instructional illustration showing how to peel and apply a Nitroglycerin Transdermal Infusion System patch. It depicts a person removing protective film from the patch with their fingers, demonstrating the proper handling before application to the skin.*

FDA Label Image

Removal Figure Image (Nitroglycerin Patch 12)

An instructional illustration demonstrating the application of a Nitroglycerin Transdermal Infusion System patch. The image shows a hand peeling the protective liner off the adhesive patch prior to placing it on the skin. It visually guides the correct handling and placement of the patch for transdermal delivery.*

FDA Label Image

20 mg Carton Box (Nitroglycerin Patch 13)

Packaging label for Nitroglycerin Transdermal Infusion System patch, 0.1 mg/hr (5 cm²) by Dr. Reddy's Laboratories, Inc. The label states each unit contains 20 mg nitroglycerin in an acrylic-based polymer adhesive with a resinous cross-linking agent. The label includes directions for use and dosing information, prescribing the patch for transdermal delivery. The package contains 30 units and is marked Rx Only.*

FDA Label Image

40 mg Carton Box (Nitroglycerin Patch 14)

Packaging label for Nitroglycerin Transdermal Infusion System 0.2 mg/hr (10 cm²) patch by Dr. Reddy's Laboratories, Inc. The label states the patch contains 40 mg of nitroglycerin in an acrylic-based polymer adhesive with a resinous cross-linking agent and indicates a rated release of 0.2 mg/hr. The carton includes usage directions, storage instructions, and notes that contents include 30 units. It is a prescription transdermal patch for human use.*

FDA Label Image

80 mg Carton Box (Nitroglycerin Patch 15)

The packaging label for Nitroglycerin Transdermal Infusion System patch delivers 0.4 mg/hr over 20 cm². It contains 80 mg of nitroglycerin in a polymer adhesive. The label includes dosing instructions, prescribing information references, storage directions, and is marked for transdermal use only. Dr. Reddy's Laboratories, Inc. is the labeler. The package holds 30 units and is Rx only.*

FDA Label Image

120 mg Carton Box (Nitroglycerin Patch 16)

Nitroglycerin Transdermal Infusion System 0.6 mg/hr (30 cm²) patch by Dr. Reddy's Laboratories. The packaging indicates each unit contains 120 mg of nitroglycerin in acrylic-based polymer adhesives with resinous cross-linking agent. The label notes a rated release in vivo of 0.6 mg/hr and contains 30 units. Usage and storage instructions are printed on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.